Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 12-2018 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | 76,453 | 6,999 |
| Receivables | N/A | 973 | 1,078 |
| Other current assets | 0 | 25 | 0 |
| TOTAL | $N/A | $77,451 | $8,077 |
| Non-Current Assets | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $77,605 | $8,077 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 956 | 442 |
| Accrued Expenses | N/A | 989 | 25 |
| TOTAL | $N/A | $1,945 | $467 |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $1,945 | $467 |
| Shareholders' Equity | |||
| Retained earnings | N/A | -17,568 | -7,630 |
| Other shareholders' equity | 0 | 93,146 | 0 |
| TOTAL | $N/A | $75,660 | $7,610 |
| Total Liabilities And Equity | $0 | $77,605 | $8,077 |